Staphylococcus aureus alpha toxin

Staphylococcus aureus alpha toxin is a pore-forming toxin secreted by some strains of the bacterium Staphylococcus aureus. It is the first member of the pore-forming toxins family to be discovered. The toxin is a major virulence factor in infections caused by S. aureus.

Structure

The alpha toxin is a single polypeptide chain of 293 amino acids. It is secreted as a water-soluble monomer that can associate with the plasma membrane of host cells. Upon binding, it undergoes a conformational change and assembles into a heptameric pore in the membrane.

Function

The alpha toxin forms pores in the cell membrane of the host organism, causing cell lysis and death. It is capable of lysing many types of cells, including erythrocytes, lymphocytes, monocytes, and platelets. The toxin also has other effects, such as inducing apoptosis and stimulating inflammatory responses.

Role in disease

The alpha toxin plays a significant role in the pathogenesis of several Staphylococcus aureus-related diseases, including pneumonia, sepsis, and skin and soft tissue infections. It is also implicated in the development of toxic shock syndrome.

Treatment and prevention

The treatment of diseases caused by alpha toxin-producing S. aureus strains typically involves the use of antibiotics. However, the emergence of antibiotic-resistant strains has led to the development of alternative strategies, such as the use of antitoxin antibodies or small molecule inhibitors.

Prevention of S. aureus infections can be achieved through good hygiene practices. Vaccines are also being developed, some of which target the alpha toxin.

See also

• Staphylococcus aureus
• Pore-forming toxins
• Toxic shock syndrome

References

Staphylococcus aureus alpha toxin Resources
Need Help Finding a Doctor? Need help finding a doctor or specialist anywhere in the world? Explore our world directory. WikiMD's DocFinder can assist you in locating millions of physicians.	Medical Knowledge Access the latest research - Most recent articles Ongoing trials.

Translate to: East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski